Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Full textbookMRCPMRCS

Respiratory physiology and gas exchange

Apply ventilation, perfusion, diffusion, compliance and gas-transport principles to calculate physiological values and distinguish mechanisms of hypoxaemia and ventilatory failure.

Saved on this device
Open the sections you need. The overview is shown first.
01Core principlesThe concepts and mechanisms needed to understand the subject.

Ventilation moves gas, while perfusion brings blood and diffusion crosses the alveolar-capillary membrane. Minute ventilation can look adequate even when alveolar ventilation is poor. If tidal volume approaches anatomical dead space, increasing respiratory rate produces little fresh gas at alveoli. Carbon dioxide elimination relates to alveolar ventilation and metabolic production. A rise in PaCO2 therefore signals inadequate effective ventilation relative to production, although the cause may lie in drive, neuromuscular power, chest mechanics, airway load or excess dead space.

Gas exchange depends on matching. An alveolus with ventilation but no perfusion contributes physiological dead space; one with perfusion but no ventilation acts as shunt. Between these extremes, low V/Q units lower arterial oxygen, while high V/Q units cannot fully compensate because haemoglobin in well-ventilated units is already near its loading plateau. The alveolar gas equation estimates alveolar oxygen from inspired oxygen, barometric pressure, water vapour, arterial carbon dioxide and respiratory quotient. Comparing estimated alveolar with measured arterial oxygen helps separate hypoventilation from additional exchange defects.

Mechanical work reflects elastic and resistive loads. Compliance equals change in volume divided by change in pressure. Fibrotic lung is less compliant, requiring a larger pressure change for a given volume; emphysematous lung may be highly compliant but has reduced elastic recoil and airway support. Surface tension would favour collapse of smaller alveoli, but surfactant reduces tension and becomes relatively more effective as alveoli shrink. Airway resistance depends strongly on radius and is normally concentrated in medium-sized airways because small airways are numerous and arranged in parallel.

Oxygen is carried mostly bound to haemoglobin, with a small dissolved component represented by partial pressure. Content therefore falls with anaemia even when saturation and PaO2 are normal. The oxyhaemoglobin dissociation curve is sigmoidal because binding is cooperative. Higher hydrogen ion, carbon dioxide, temperature or 2,3-BPG shifts affinity to favour tissue unloading; opposite changes favour loading. Carbon dioxide travels dissolved, as bicarbonate and as carbamino compounds. Acid-base chemistry and chloride movement allow red cells to transport large carbon dioxide loads.

Key points

  • Minute ventilation equals tidal volume times respiratory rate, but alveolar ventilation subtracts dead-space volume before multiplying; rapid shallow breathing can therefore waste most ventilation.
  • Alveolar carbon dioxide varies inversely with alveolar ventilation when carbon dioxide production is stable, making hypercapnia principally a problem of inadequate effective ventilation.
  • Ventilation-perfusion matching is regional: low V/Q lowers oxygenation, high V/Q wastes ventilation, and true shunt responds less to increased inspired oxygen than ordinary V/Q mismatch.
  • Diffusion depends on area, thickness, diffusion coefficient and partial-pressure gradient; fibrosis reduces conductance by thickening the barrier, while emphysema reduces surface area.
  • Compliance is volume change per pressure change; surfactant lowers surface tension, improves stability of small alveoli and reduces the work needed to inflate lung.
  • Oxygen content depends mainly on haemoglobin concentration and saturation, whereas partial pressure describes dissolved oxygen and drives diffusion; normal PaO2 does not guarantee normal oxygen content.
02Mechanisms and patternsImportant relationships and how to distinguish them.
Alveolar hypoventilation

Inadequate alveolar ventilation raises PaCO2 and lowers alveolar oxygen; a normal A–a gradient supports a predominantly ventilatory mechanism.

V/Q mismatch

Unequal ventilation relative to perfusion is a common hypoxaemic mechanism and often improves with added inspired oxygen, depending on severity.

True shunt

Blood reaching arterial circulation without contacting ventilated alveoli produces hypoxaemia that is relatively resistant to increased inspired oxygen.

Diffusion limitation

Reduced area or increased barrier thickness impairs equilibration, especially when transit time shortens during exercise.

Dead-space ventilation

Ventilation of unperfused or poorly perfused regions consumes tidal volume without equivalent carbon dioxide exchange.

Content-pressure dissociation

PaO2 can remain normal despite low oxygen content in anaemia, while dyshemoglobinaemia can disrupt the relation between pressure, saturation and usable carriage.

03Interpreting evidenceInformation, measurements and their limitations.
Reasoning sequence

Consider the information, its meaning and its limitations before deciding what follows.

  1. 01
    Alveolar-ventilation calculation
    Why
    Quantify effective fresh-gas delivery after accounting for physiological dead space.
    Interpretation and limitations
    Use respiratory rate multiplied by tidal volume minus dead-space volume; do not substitute minute ventilation when breath depth changes.
  2. 02
    Alveolar gas equation
    Why
    Estimate alveolar oxygen and derive the A–a oxygen difference.
    Interpretation and limitations
    State inspired fraction, pressure assumptions and respiratory quotient; supplemental oxygen and altitude materially change inputs.
  3. 03
    Blood-gas pattern analysis
    Why
    Separate oxygenation, ventilation and acid-base components.
    Interpretation and limitations
    Interpret PaO2, PaCO2, pH and bicarbonate with inspired oxygen, sample type and timing; one value cannot define the mechanism alone.
  4. 04
    Oxygen-content reasoning
    Why
    Distinguish dissolved pressure from haemoglobin-bound oxygen carriage.
    Interpretation and limitations
    Content depends strongly on haemoglobin and saturation; tissue delivery additionally requires cardiac output and distribution.
  5. 05
    Flow-volume and volume analysis
    Why
    Relate obstruction, restriction and gas trapping to mechanical physiology.
    Interpretation and limitations
    Effort, technique and reference values matter; spirometry can suggest patterns but does not by itself name the structural cause.
  6. 06
    Response-to-oxygen reasoning
    Why
    Use physiological response to refine hypoxaemia mechanism while treating appropriately.
    Interpretation and limitations
    Poor response can suggest substantial shunt or extreme disease, but delivered concentration, ventilation and measurement quality must be verified.
04Applied reasoningWorked examples connecting principles to decisions.
01Worked exampleCalculate alveolar ventilationA model adult breathes 12 times per minute with tidal volume 500 mL and anatomical dead space 150 mL; carbon dioxide production is stable. Assume alveolar dead space is negligible, so physiological dead space equals the stated anatomical dead space.
  1. 1Calculate fresh gas per breath by subtracting dead space from tidal volume: 500 minus 150 equals 350 mL.
  2. 2Multiply 350 mL by 12 breaths per minute to obtain 4200 mL/min.
  3. 3The final alveolar ventilation is 4.2 L/min, whereas minute ventilation is 6.0 L/min.
  4. 4Predict that switching to 30 breaths/min at 200 mL with the same dead space would yield only 1.5 L/min alveolar ventilation despite unchanged 6.0 L/min minute ventilation.
  5. 5Verify each unit and use the contrast to confirm why rapid shallow breathing can cause carbon dioxide retention.
02Gas-exchange reasoningInterpret hypoxaemia with normal A–a differenceA blood gas on a known inspired oxygen fraction shows raised PaCO2, reduced PaO2 and an age-appropriate A–a oxygen difference.
  1. 1Use raised carbon dioxide as evidence that effective alveolar ventilation is inadequate relative to production.
  2. 2Recognise that the normal A–a difference argues against a major additional transfer or matching defect.
  3. 3Classify alveolar hypoventilation as the dominant mechanism while investigating its cause.
  4. 4Check inspired oxygen, barometric assumptions and sample validity before treating the gradient as definitive.
03Transport reasoningCompare anaemia with hypoxaemiaOne model has low haemoglobin with normal saturation and PaO2; another has normal haemoglobin but reduced saturation.
  1. 1Separate dissolved oxygen pressure from haemoglobin binding capacity.
  2. 2Predict reduced arterial oxygen content in the anaemic model despite a normal PaO2.
  3. 3Calculate or compare haemoglobin-bound content for both when numerical inputs are supplied.
  4. 4Extend to delivery by considering cardiac output, showing why PaO2 alone cannot describe tissue oxygen supply.
05Checking understandingVerify the reasoning, revisit uncertainties and apply feedback.
  • Recheck ventilation calculations whenever tidal volume changes because dead space is subtracted per breath rather than per minute.
  • State inspired oxygen and sampling context beside every blood-gas interpretation.
  • Use mechanism tables to distinguish hypoventilation, V/Q mismatch, shunt and diffusion limitation by PaCO2, A–a difference and oxygen response.
  • Verify oxygen-content reasoning with haemoglobin and saturation instead of treating PaO2 as total carriage.
  • Review mechanical predictions with pressure-volume curves, identifying whether compliance, resistance or both have changed.
06Special situationsVariants, exceptions and circumstances that change the usual approach.

Shunt cannot be ventilated

Increasing ventilation to already open units cannot oxygenate blood bypassing them, which explains the limited correction of a large true shunt.

High V/Q has limited compensation

Well-ventilated blood gains little extra bound oxygen once haemoglobin is near saturation, so it cannot fully offset low-V/Q blood.

Compliance and recoil diverge

High compliance can coexist with poor expiratory recoil, while low compliance increases inspiratory pressure work.

Mixed venous oxygen matters

Lower incoming venous oxygen amplifies arterial hypoxaemia produced by shunt or low V/Q, especially when tissue extraction rises.

Delivery exceeds content

Oxygen delivery is the product of content and cardiac output, so circulation can compensate for, or worsen, a carriage problem.

07Common pitfallsFrequent interpretation and management errors.
  1. 01

    Using minute ventilation to explain carbon dioxide clearance without subtracting dead space.

  2. 02

    Calling every low PaO2 diffusion failure instead of comparing ventilation, matching, shunt and inspired oxygen.

  3. 03

    Assuming supplemental oxygen corrects a large true shunt as effectively as ordinary V/Q mismatch.

  4. 04

    Equating normal PaO2 with normal oxygen content in a patient with altered haemoglobin.

  5. 05

    Describing emphysema as a low-compliance disorder because the patient has increased work of breathing.

Practice

Two practice questions

Question 1 of 20 correct
Applied basic sciencesOriginal SBA

Calculating effective ventilation

A model adult has tidal volume 500 mL, anatomical dead space 150 mL and respiratory rate 12 per minute. Assuming negligible alveolar dead space, what is alveolar ventilation?

Sources and review status6 sources · checked 7 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 7 Sept 2026; clinical approval remains outstanding.

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom